PPARγ is the main type of PPAR in adipose tissue, and is a major target for drug development in T2D,22,23 suggesting that 3HB could act as an insulin resistance reduction agent through PPARγ signaling pathway. The gene discussed is PPARG; the disease is Insulin resistance.